Sleepiness, parkinsonian features and sustained attention in mild Alzheimer's disease

Age and Ageing

Volumn 41, Issue 6, 2012, Pages 765-770

  Park, Margaret ^a   Hood, Megan M ^a   Shah, Raj C ^a,b   Fogg, Louis F ^a   Wyatt, James K ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Attention; Older people; Parkinsonian features; Psychomotor vigilance test; Sleepiness

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; DAYTIME SOMNOLENCE; DISEASE SEVERITY; HUMAN; MINI MENTAL STATE EXAMINATION; PARASOMNIA; PARKINSONISM; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SLEEP DISORDERED BREATHING; SOMNOLENCE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATTENTION; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; POLYSOMNOGRAPHY; PSYCHOMOTOR PERFORMANCE; RISK FACTORS; SLEEP DISORDERS;

EID: 84867794434     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afs084     Document Type: Article

References (30)

1. Perry RJ, Hodges JR. Attention and executive deficits in Alzheimer's disease. A critical review. Brain 1999; 122(Pt 3)(Pt 3): 383-404.
2. Parasuraman R, Nestor PG. Attention and driving skills in aging and Alzheimer's disease. Hum Factors 1991; 33: 539-57.
3. Duchek JM, Hunt L, Ball K, Buckles V, Morris JC. The role of selective attention in driving and dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 1997; 11(Suppl. 1): 48-56.
4. Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA 1987; 257: 1492-5.
5. Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2001; 16: 494-8.
6. Goel N, Rao H, Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol 2009; 29: 320-39.
7. Lim J, Dinges DF. A meta-analysis of the impact of shortterm sleep deprivation on cognitive variables. Psychol Bull 2010; 136: 375-89.
8. Ferman TJ, Smith GE, Boeve BF et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004; 62: 181-7.
9. Dinges DF, Powell JW. Microcomputer analysis of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods Instrum Comput 1985; 6: 652-5.
10. Doran SM, Van Dongen HP, Dinges DF. Sustained attention performance during sleep deprivation: evidence of state instability. Arch Ital Biol 2001; 139: 253-67.
11. Lim J, Dinges DF. Sleep deprivation and vigilant attention. Ann N Y Acad Sci 2008; 1129: 305-22.
12. Warm JS, Parasuraman R, Matthews G. Vigilance requires hard mental work and is stressful. Hum Factors 2008; 50: 433-41.
13. Jewett ME, Dijk DJ, Kronauer RE, Dinges DF. Doseresponse relationship between sleep duration and human psychomotor vigilance and subjective alertness. Sleep 1999; 22: 171-9.
14. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003; 26: 117-26.
15. Philip P, Akerstedt T. Transport and industrial safety, how are they affected by sleepiness and sleep restriction? Sleep Med Rev 2006; 10: 347-56.
16. Lee JH, Bliwise DL, Ansari FP et al. Daytime sleepiness and functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 2007; 15: 620-6.
17. Park M, Shah RC, Fogg LF, Wyatt JK. Daytime sleepiness in mild Alzheimer's disease with and without parkinsonian features. Sleep Med 2011; 12: 397-402.
18. Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health genetics initiative. Arch Neurol 1994; 51: 1198-204.
19. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983; 17: 37-49.
20. Bennett DA, Shannon KM, Beckett LA, Wilson RS. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 1999; 54: M191-6.
21. Clark CM, Ewbank D, Lerner A et al. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1997; 49: 70-5.
22. Littner MR, Kushida C, Wise M et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28: 113-21.
23. Wyatt JK, Ritz-De Cecco A, Czeisler CA, Dijk DJ. Circadian temperature and melatonin rhythms, sleep, and neurobehavioral function in humans living on a 20-h day. Am J Physiol 1999; 277(4 Pt 2): R1152-63.
24. Dinges DF. A very brief probed-recall memory task: sensitivity to sleep loss (abstract). Sleep Res 1993; 22: 330.
25. Basner M, Dinges DF. Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep 2011; 34: 581-91.
26. Walker MP, Ayre GA, Ashton CH et al. A neuropsychophysiological investigation of fluctuating consciousness in neurodegenerative dementias. Human Psychopharmacol 1999; 14: 483-9.
27. Ballard CG, Aarsland D, McKeith I et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002; 59: 1714-20.
28. Lee DR, Taylor JP, Thomas AJ. Assessment of cognitive fluctuation in dementia: a systematic review of the literature. Int J Geriatr Psychiatry 2012; doi: 10.1002/gps.2823.
29. Zhou JN, Hofman MA, Swaab DF. VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging 1995; 16: 571-6.
30. Wu YH, Feenstra MG, Zhou JN et al. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab 2003; 88: 5898-906.